Reflux and Helicobacter pylori

Current Opinion in Gastroenterology

Volumn 13, Issue SUPPL. 1, 1997, Pages 43-47

  De Koster, Erik ^a   Kuipers, Ernst J ^b  

^a BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ATROPHIC GASTRITIS; DISEASE SEVERITY; DRUG EFFICACY; DUODENUM ULCER; ESOPHAGITIS; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HUMAN; RISK FACTOR; SHORT SURVEY; STOMACH PROTECTION;

EID: 0030761450     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (35)

1. Newton M, Bryan R, Burnham WR, Kamm MA: Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus. Gut 1997, 40:9-13. In several small patient groups H. pylori was equally common in patients with GERD as in controls.
2. Mihara M, Haruma K, Kamada T, Klyohira K, Goto T, Sumii M, Tanaka S, Yoshihara M, Sumii K, Kajiyama G: Low prevalence of Helicobacter pylori infection in patients with reflux oesophagitis. Gut 1996, 39(suppl 2):A94.
3. Werdmuller BF, Loffeld RJ: Helicobacter pylori infection has no role in the pathogenesis of reflux oesophagitis. Dig Dis Sci 1997, 42:103-105. A larger study showing that H. pylori actually is less common in GERD patients than in controls.
4. Hirschl AM, Schutze K, Hentschel E, Dragosics B: Serological, microbiological and clinical results of a 43 months follow-up after successful eradication of H. pylori in duodenal ulcer patients. Am J Gastroenterol 1994, 89:1374.
5. Labenz J, Tillenburg B, Peitz U, Borsch G: Long-term consequences of Helicobacter pylori eradication: Clinical aspects. Scand J Gastroenterol 1996, 31(suppl 215):111-115.
6. Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G: Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997, 112:1442-1447. A 3-year case-control follow-up study reporting that H. pylori eradication doubles the incidence of reflux esophagitis in duodenal ulcer patients.
7. Sacca N, De Medici A, Rodino S, De Siena M, Giglio A: Reflux eosphagitis: a complication of Helicobacter pylori eradication therapy? Gut 1996, 39(suppl 2):A91.
8. Schenk BE, Kuipers EJ, Klinkenberg-Knoll EC, Eskes SA, Meuwissen SGM: H. pylori, GERD and efficacy of omeprazole therapy. Gastroenterology 1997, 112:A282.
9. El-Seraq HB, Sonnenberg A: Opposing time trends of peptic ulcer and reflux disease. Gastroenterology 1997, 112:A113.
10. De Koster E, Ferhat M, Deprez C, Deltenre M: Helicobacter pylori, gastric histology and gastro-oesophageal reflux disease. Gut 1995, 37(suppl 1):A36.
11. Ruiz B, Correa P, Fontham ETH, Ramakrishnan T: Antral atrophy, Helicobacter pylori colonization, and gastric pH. Am J Clin Pathol 1996, 105:96-101.
12. Furuta T, Takashima M, Futami H, Arai H, Ito G, Kajimura M, Hanai H, Kaneko E: Effect of Helicobacter pylori on gastric acid. Gastroenterology 1997, 112:A121.
13. Verdu EF, Armstrong D, Fraser R, Viani F, Idstrom J, Cederberg C, Blum AL: Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole. Gut 1995, 36:539-543.
14. Verdu EF, Armstrong D, Idstrom J-P, Labenz J, Stolte M, Dorta G, Borsch G, Blum AL: Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole. Gut 1995, 37:743-748.
15. Labenz J, Tillenburg B, Peitz U, Idstrom JP, Verdu EF, Stolte M, Borsch G, Blum AL: Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 1996, 110:725-732. In duodenal ulcer patients H. pylori eradication does not affect the baseline pH. However, the efficacy of omeprazole in augmenting the gastric pH diminishes after H. pylori eradication.
16. Labenz J, Tillenburg B, Peitz U, Idstrom JP, Verdu E, Stolte M, Borsch G, Blum AL: Efficacy of omeprazole one year after cure of H. pylori infection in duodenal ulcer patients. Gut 1996, 39(suppl 2):A93.
17. Tillenburg B, Blum AL, Peitz , Verdu E, Borsch G, Stolte M, Labenz J: Cure of H. pylori infection decreases the antisecretory effect of rantidine in duodenal ulcer patients. Gut 1996, 39(suppl 2):A98.
18. Logan RPH, Walker MM, Misiewicz JJ, Gummett PA, Karim QN, Baron JH: Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 1995, 36:12-16.
19. Kuipers EJ, Uyterlinde AM, Pena AS, Hazenberg HJA, Bloemena E, Lindeman J, Klinkenberg-Knol EC, Meuwissen SGM: Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: Implications for long-term safety. Am J Gastroenterol 1995, 90:1401-1406.
20. Berstad AE, Hatlebakk JG, Maartmann-Moe H, Berstad A, Brandtzaeg P: Helicobacter pylori-infected patients show increased inflammation in gastric body mucosa during long-term treatment with lansoprazole. Gut 1996, 39(suppl 2):A104.
21. Eissele R, Brunner G, Simon B, Solcia E, Arnold R: Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophy-cell hyperplasia. Gastroenterology 1997, 112:707-715. A maximum five year follow-up study of patients treated with 30-90 mg lansoprazole. This therapy induced a worsening chronic active inflammation in non-antrectomized patients with H. pylori infection, which within the first 5 years of treatment led to more than double (21-46%) the prevalence of corpus mucosal atrophy.
22. Kuipers EJ, Uyterlinde AM, Pena AS, Roosendaal R, Pals G, Nelis GF, Festen HPM, Meuwissen S: Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995, 345:1525-1528.
23. Correa P: Human gastric carcinogenesis: a multistep and multi-factorial process. Cancer Res 1992, 52:6735-6740.
24. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, Havu N, Festen HPM, Liedman B, Lamers CBHW, Jansen JBMJ, Dalenback J, Snel P, Nelis GF, Meuwissen SGM: Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996, 334:1018-1022. Long term treatment with proton pump inhibitors may accelerate the development of atrophic gastritis in H. pylori positive GERD patients; this is not the case for H. pylori negative patients or H. pylori positive patients treated with fundoplication. This article is the major argument in favour of diagnosing and treating H. pylori in patients treated with long term proton pump inhibitors.
25. Ihamaki T, Saukkonen M, Siurala M: Long-term observation of subjects with normal gastric mucosa and with superficial gastritis: results of 23-27 years follow-up examinations. Scand J Gastroenterol 1978, 13:771-775.
26. Correa P, Haenszel W, Cuello C, Zavala D, Fontham E, Zarama G, Tannenbaum S, Collazos T, Ruiz B: Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res 1990, 50:4737-4740.
27. Villako K, Kekki M, Maaroos HI, Sipponen P, Uibo R, Tammur R, Tamm A: Chronic gastritis: progression of inflammation and atrophy in a six year endoscopic follow-up of a random sample of 142 Estonian urban subjects. Scand J Gastroenterol Suppl 1991, 186:135-141.
28. Maaroos HI, Salupere V, Uibo R, Kekki M, Sipponen P: Seven-year follow-up study of chronic gastritis in gastric ulcer patients. Scand J Gastroenterol 1985, 20:198-204
29. Jonsson LA, Strom M, Bodernar G, Norrby K: Histologic changes in the gastroduodenal mucosa after long-term medical treatment with cimetidine or parietal cell vagotomy in patients with juxtapyloric ulcer disease. Scand J Gastroenterol 1988, 23:433-441.
30. Lamberts R, Creutzfeldt W, Struber HG, Brunner G, Solcia E: Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. Gastroenterology 1993, 104:1356-1370.
31. Solda R, Fiocca R, Havu N, Datvag A, Carlsson R: Gastric endocrine cells and gastritis in patients receiving long-term omeprazole treatment. Digestion 1992, 51 (Suppl 1):82-92.
32. Ladas SD, Katsogridakis J, Malamou H, Giannopoulou H, Kessa-Elia M, Raptis SA: Helicobacter pylori may induce bile reflux: link between H. pylori and bile induced injury to gastric epithelium. Gut 1996, 38:15-18.
33. Bechi P: Helicobacter pylori and duodenogastric reflux. Gut 1996, 39:773-774.
34. Bechi P: Bilitec and 'quantitation' of reflux: further acid comments. Gastroenterology 1995, 109:1023-1024.
35. Blaser MJ: All Helicobacters pylori are not created equal: should all be eliminated? Lancet 1997, 349:1020-1022. Opinion paper which emphasizes the need for a further understanding of the clinical relevance of H. pylori diversity and the potential benefits of H. pylori colonization.